Effects of PEG tethering chain length of vitamin E TPGS with a Herceptin-functionalized nanoparticle formulation for targeted delivery of anticancer drugs.
Drug formulation by ligand conjugated nanoparticles of biodegradable polymers has become one of the most important strategies in drug targeting. We have developed in our previous work nanoparticles of a mixture of two vitamin E TPGS based copolymers PLA-TPGS and TPGS-TOOH with the latter for Herceptin conjugation for targeted delivery of anticancer drugs such as docetaxel to the cancer cells of human epidermal growth factor receptor 2 (HER2) overexpression. In this research, we investigated the effects of the PEG chain length in TPGS, which is in fact a PEGylated vitamin E, on the cellular uptake and cytotoxicity of the drug formulated in the Herceptin-conjugated nanoparticles of PLA-TPGS/TPGS-COOH blend (NPs). Such NPs of PEG1000, PEG2000, PEG3350 and PEG5000, i.e. the PEG of molecule weight 1000, 2000, 3350 and 5000, were prepared by the nanoprecipitation method and characterized for their size and size distribution, drug loading, surface morphology, surface charge and surface chemistry as well as in vitro drug release profile, cellular uptake and cytotoxicity. We found among such nanoparticles, those of PEG1000, i.e. of the shortest PEG tethering chain length, could result in the best therapeutic effects, which are 24.1%, 37.3%, 38.1% more efficient in cellular uptake and 68.1%, 90%, 92.6% lower in IC50 (thus higher in cytotoxicity) than the Herceptin-conjugated nanoparticles of PLA-TPGS/TPGS-COOH blend of PEG2000, PEG3350 and PEG5000 respectively in treatment of SK-BR-3 cancer cells which are of high HER2 overexpression. We provided a theoretical explanation from surface mechanics and thermodynamics for endocytosis of nanoparticles.
Department of Bioengineering, National University of Singapore, Block EA, 03-12, 9 Engineering Drive 1, Singapore 117575, Singapore.
Jing
J
Zhao
Department of Bioengineering, National University of Singapore, Block EA, 03-12, 9 Engineering Drive 1, Singapore 117575, Singapore; Department of Chemical & Biomolecular Engineering, National University of Singapore, Block E5, 02-11, 4 Engineering Drive 4, Singapore 117576, Singapore; NanoCore, National University of Singapore, Block EA, 04-27, 9 Engineering Drive 1, Singapore 117576, Singapore. Electronic address: chefss@nus.edu.sg.
Si-Shen
SS
Feng
D061067:Antibodies, Monoclonal, Humanized / Q000737:chemistry*; D001672:Biocompatible Materials; D045744:Cell Line, Tumor; D004337:Drug Carriers; D006801:Humans; D008855:Microscopy, Electron, Scanning; D053758:Nanoparticles; D011092:Polyethylene Glycols / Q000737:chemistry*; D000068878:Trastuzumab; D014810:Vitamin E / Q000737:chemistry*
D061067:Antibodies, Monoclonal, Humanized; D001672:Biocompatible Materials; D004337:Drug Carriers; D014810:Vitamin E; D011092:Polyethylene Glycols; D000068878:Trastuzumab
Biodegradable polymers; Cancer nanotechnology; Drug delivery; Drug targeting; Nanomedicine; Pharmaceutical nanotechnology